Disruption of the brain growth spurt in adolescent rats by chronic phenobarbital administration

Experimental Neurology
|February 1, 1983
PubMed

Insights

High-dose phenobarbital disrupted brain growth in young rats, causing smaller brains and larger livers. This suggests barbiturates may threaten normal brain development even late in its stages.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Phenobarbital is a widely used barbiturate medication.
  • Brain development continues into the postweanling period.
  • Environmental factors can impact neurodevelopment.

Purpose of the Study:

  • To investigate the effects of phenobarbital on brain and liver growth in postweaning rats.
  • To determine if late-stage brain development is vulnerable to barbiturate exposure.

Main Methods:

  • Postweanling rats (postnatal days 25-39) received daily injections of phenobarbital (60 mg/kg or 15 mg/kg) or vehicle.
  • Body weight, whole brain weight, and liver weight were measured.

Main Results:

  • No significant differences in body weight were observed among groups.
  • Rats receiving 60 mg/kg phenobarbital exhibited significantly smaller whole brain weights compared to controls.
  • The high-dose phenobarbital group showed significantly larger liver weights.

Conclusions:

  • Late-stage brain growth is vulnerable to disruption by phenobarbital.
  • Barbiturate exposure may pose a threat to normal brain development.
  • Phenobarbital exposure can lead to organ-specific growth alterations.

Related Concept Videos